Faculty

Institution

Unit

Venue

Daniel Verina

Nurse Practitioner; Part time faculty

William Paterson University of New Jersey

Affiliations

College of Science and Health

School of Nursing

Nursing

Daniel Verina is currently serving as a College Of Science And Health Nurse Practitioner; Part time faculty at William Paterson University of New Jersey.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Daniel Verina

William Paterson University of New Jersey

Nurse Practitioner; Part time faculty

You can click a keyword to filter the displayed items

medicine immunology hematology hematological malignancies leukemia vaccination vaccines multiple myeloma infectious diseases oncology lymphoid neoplasia triple mapk inhibition sars-cov-2 immune responses cellular therapy malignant blood disorders covid-19 immunity (medicine) antiviral research medical virology cancer cells cellular immune responses humoral response cell therapy myeloma patients molecular biology cell death virus research oncogenes thoracic oncology thrombosis respiratory medicine infection control cancer care virus eradication bone marrow transplantation clinical transplantation adaptive immune system clinical immunology post-operative care immune checkpoint inhibitors pulmonary vascular disease pulmonary embolism venous thrombosis clinical infection disease progression antiviral responses novel therapies cell replacement therapies viral neutralization subcutaneous daratumumab phase ii study sub-optimal immune responses cellular mechanisms gaucher disease lung complications infection prophylaxis bispecific antibody therapy disease response refractory multiple myeloma associated viral neutralization third-dose sars-cov-2 vaccination nursing biology

Notable Scholarly Works

Notable Federal Grants

Collaborators

P-083 Simultaneous Progressive Multifocal Leukoencephalopathy and Bk Virus-Nephropathy Associated With Bispecific Antibody Therapy in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia (2024)

Ariel SiegelJohn CraryDaniel VerinaAmanda KrausertSundar JagannathSamir Parekh

bispecific antibody therapyimmunologyleukemialymphoid neoplasiamultiple myeloma

Regression of Smoldering Myeloma With Treatment of Gaucher Disease. Blood Advances (2024)

Kevin BarleyAnshuman ParekhSyed SalamDamodara Rao MenduRavi Prakash ShuklaDeepa VattiDaniel VerinaChanan StaufferChristian SalibSiraj El JamalJulie Teruya-FeldsteinAmy S. DuffieldVioletta V. LeshchenkoSundar JagannathManisha BalwaniSamir Parekh

gaucher diseasehematologyhematological malignanciesmedicineoncology

Cellular Mechanisms Associated With Sub-Optimal Immune Responses to Sars-Cov-2 Bivalent Booster Vaccination in Patients With Multiple Myeloma. EBioMedicine (2023)

Adolfo AlemanMorgan van KesterenAriel Kogan ZajdmanKomal SrivastavaChristian CognigniJacob MischkaLucia Y. ChenBhaskar UpadhyayaKseniya SerebryakovaJessica R. NardulliNeko LyttleKaterina KappesHayley JacksonCharles R. GleasonAnnika OosteninkGianna Y. CaiOliver Van OekelenHarm van BakelEmilia Mia SordilloCarlos Cordon-CardoMiriam MeradSundar JagannathAnia WajnbergViviana SimonSamir ParekhHala AlshammaryDalles AndreRadhika BanuKatherine BeachMaría Carolina Bermúdez-GonzálezAjai ChariYuexing ChenHearn ChoAdolfo FirpoAna Silvia Gonzalez-ReicheEun Hye KimGiulio KleinerFlorian KrammerJacob MauldinRao MenduBrian MonahanShambavi RichardJoshua RichterCesar RodriguezAdrianna RossiAshley SalimbangonLaryssa SanchezDaniel Verina

sub-optimal immune responsesinfectious diseasesvaccinesvaccinationimmunologysars-cov-2immune responsesimmunity (medicine)medicinecellular immune responsescellular mechanismsmultiple myeloma

CORRECTION: Triple Mapk Inhibition Salvaged a Relapsed Post-Bcma Car-T Cell Therapy Multiple Myeloma Patient With a Braf V600E Subclonal Mutation. Journal of Hematology & Oncology (2023)

Muhammad ElnaggarSarita AgtePaula RestrepoMeghana RamDavid MelnekoffChristos AdamopoulosMark M StevensKaterina KappesVioletta LeshchenkoDaniel VerinaSundar JagannathPoulikos I PoulikakosSamir ParekhAlessandro Laganà

cell therapytriple mapk inhibitionhematologycellular therapymedicineoncology

A Focus on Newly Diagnosed Multiple Myeloma. Journal of the Advanced Practitioner in Oncology (2022)

radiation oncologyhematological malignancieshematologycancer researchmultiple myelomacancer careoncologymalignant blood disorders

Augmentation of Humoral and Cellular Immune Responses After Third-Dose Sars-Cov-2 Vaccination and Associated Viral Neutralization in Myeloma Patients. (2022)

infectious diseasesassociated viral neutralizationvaccinesantiviral responsesvaccinationimmunologymyeloma patientssars-cov-2antiviral researchthird-dose sars-cov-2 vaccinationimmune responsesimmunity (medicine)humoral responsemedical virologyvirus eradication

Augmentation of Humoral and Cellular Immune Responses After Third-Dose Sars-Cov-2 Vaccination and Viral Neutralization in Myeloma Patients. Cancer Cell (2022)

Adolfo AlemanOliver Van OekelenBhaskar UpadhyayaKatherine BeachAriel Kogan ZajdmanHala AlshammaryKseniya SerebryakovaSarita AgteKaterina KappesCharles R. GleasonKomal SrivastavaSteve AlmoCarlos Cordon-CardoFlorian KrammerMiriam MeradSundar JagannathAnia WajnbergViviana SimonSamir ParekhD. AndreA. AzadR. BanuM.C. Bermúdez-GonzálezG. CaiA. ChariH. ChoC. CognigniK. DavidD. FlodaA. FirpoG. KleinerN. LyttleW. MendezL.C.F. MulderR. MenduA. OosteninkA. RookerS. RichardJ. RichterC. RodriguezA. RossiK. RussoL. SanchezA. SalimbangonM. SaksenaA. ShinL. SominskyD. Verina

vaccinescell deathimmunologycellular immune responsesadaptive immune systemcovid-19clinical immunologyinfectious diseasesvaccinationmyeloma patientsmolecular biologyhumoral responsecancer cellsvirus researchhematological malignanciesviral neutralizationsars-cov-2antiviral researchimmune responsesmedical virology

Extramedullary Relapse Post Car-T. Blood (2022)

Shambavi RichardGuido LancmanAdriana RossiAjai ChariSamir ParekhLarysa SanchezCesar RodriguezHearn J. ChoJoshua RichterSantiago ThibaudKiah PurcellElizabeth AronsonDaniel VerinaJuliet EscalonKaren LouwSundar Jagannath

post-operative caremedicinehematology

Immune Recovery Post Bcma Car-T: Implications for Infection Prophylaxis and Vaccinations. Blood (2022)

Shambavi RichardGuido LancmanSantiago ThibaudAjai ChariSamir ParekhAdriana RossiHearn J. ChoLarysa SanchezJoshua RichterCesar RodriguezElizabeth AronsonKaren LouwKiah PurcellDaniel VerinaJuliet EscalonSundar Jagannath

infectious diseasesvaccinesinfection prophylaxisvaccinationimmunologyclinical infectioninfection control

Triple Mapk Inhibition Salvaged a Relapsed Post-Bcma Car-T Cell Therapy Multiple Myeloma Patient With a Braf V600E Subclonal Mutation. Journal of Hematology & Oncology (2022)

oncogenesradiation oncologycancer immunotherapyimmunologytriple mapk inhibitionhematological malignanciesimmunotherapycellular therapyleukemiaimmune checkpoint inhibitorsoncologymalignant blood disorders

1
2
10 / page

Daniel Verina

Nurse Practitioner; Part time faculty

William Paterson University of New Jersey

Affiliations

College of Science and Health

School of Nursing

Nursing

Daniel Verina is currently serving as a College Of Science And Health Nurse Practitioner; Part time faculty at William Paterson University of New Jersey.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Daniel Verina

William Paterson University of New Jersey

Nurse Practitioner; Part time faculty

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

P-083 Simultaneous Progressive Multifocal Leukoencephalopathy and Bk Virus-Nephropathy Associated With Bispecific Antibody Therapy in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia (2024)

Ariel SiegelJohn CraryDaniel VerinaAmanda KrausertSundar JagannathSamir Parekh

bispecific antibody therapyimmunologyleukemialymphoid neoplasiamultiple myeloma

Regression of Smoldering Myeloma With Treatment of Gaucher Disease. Blood Advances (2024)

gaucher diseasehematologyhematological malignanciesmedicineoncology

Cellular Mechanisms Associated With Sub-Optimal Immune Responses to Sars-Cov-2 Bivalent Booster Vaccination in Patients With Multiple Myeloma. EBioMedicine (2023)

sub-optimal immune responsesinfectious diseasesvaccinesvaccinationimmunologysars-cov-2immune responsesimmunity (medicine)medicinecellular immune responsescellular mechanismsmultiple myeloma

CORRECTION: Triple Mapk Inhibition Salvaged a Relapsed Post-Bcma Car-T Cell Therapy Multiple Myeloma Patient With a Braf V600E Subclonal Mutation. Journal of Hematology & Oncology (2023)

cell therapytriple mapk inhibitionhematologycellular therapymedicineoncology

A Focus on Newly Diagnosed Multiple Myeloma. Journal of the Advanced Practitioner in Oncology (2022)

radiation oncologyhematological malignancieshematologycancer researchmultiple myelomacancer careoncologymalignant blood disorders

Augmentation of Humoral and Cellular Immune Responses After Third-Dose Sars-Cov-2 Vaccination and Associated Viral Neutralization in Myeloma Patients. (2022)

Augmentation of Humoral and Cellular Immune Responses After Third-Dose Sars-Cov-2 Vaccination and Viral Neutralization in Myeloma Patients. Cancer Cell (2022)

Extramedullary Relapse Post Car-T. Blood (2022)

post-operative caremedicinehematology

Immune Recovery Post Bcma Car-T: Implications for Infection Prophylaxis and Vaccinations. Blood (2022)

infectious diseasesvaccinesinfection prophylaxisvaccinationimmunologyclinical infectioninfection control

Triple Mapk Inhibition Salvaged a Relapsed Post-Bcma Car-T Cell Therapy Multiple Myeloma Patient With a Braf V600E Subclonal Mutation. Journal of Hematology & Oncology (2022)

1
2
10 / page